Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO

NCT ID: NCT01692938

Last Updated: 2017-05-10

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

32 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-10-31

Study Completion Date

2012-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To conduct a precision study to assess the microperimetry function of the Spectral OCT/SLO. The study will assess variability across measurements taken by three different operator-device configuration across clinical sites, variability between subjects within a given operator-device configuration, and variability within a subject for a single operator-device configuration.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Age-Related Macular Degeneration Geographic Atrophy Diabetic Retinopathy Macular Edema Retinal Vein Occlusion Central Serous Retinopathy Pattern Dystrophy of Macula Epiretinal Membrane Macular Hole

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No Retinal Disease

No interventions assigned to this group

Retinal Disease

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject must be 21 years of age or older.
* Subjects recruited to Cohort 1 will have no known retinal disease except for refractive errors (-7.5 D to +7.5 diopters).Subjects who are recruited to Cohort 2 will have one or more of the following retinal pathologies: early and intermediate Age-Related Macular Degeneration, Geographic Atrophy, Diabetic Retinopathy (mild, moderate, severe), Macular Edema secondary to Diabetes, Retinal Vein Occlusion, Central Serous Retinopathy, Pattern Dystrophy, Epiretinal Membrane or Macular Hole.
* Subjects who have signed an informed consent form.
* Subjects who can comply with the protocol.

Exclusion Criteria

* Subjects younger than 21 years of age.
* Subjects who cannot comply with the protocol.
* Subjects who cannot complete the Simple Test procedures
* Subjects who are not available to be testing 3 times during the day (Morning, Mid - Day, and Afternoon).
* Subjects with visual acuity worse than 20/100 (Best Corrected).
* Subjects with dense media opacities.
* Ocular surgery anticipated on the day of the study visit.
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Johns Hopkins University

OTHER

Sponsor Role collaborator

University of Southern California

OTHER

Sponsor Role collaborator

Optos, PLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Quan Nguyen

Role: PRINCIPAL_INVESTIGATOR

Johns Hopkins University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Retina Group of Florida

Fort Lauderdale, Florida, United States

Site Status

Johns Hopkins Unversity

Baltimore, Maryland, United States

Site Status

Valley Retina Institute

McAllen, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OPT1001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of OCT Measurements
NCT01806402 COMPLETED
Dual Wavelength OCT
NCT03843840 COMPLETED
Retinal Investigation Using Optos OCT Device
NCT06846151 NOT_YET_RECRUITING NA
OCT Biomarkers for Diabetic Retinopathy
NCT02330042 ACTIVE_NOT_RECRUITING
OCT Angiography in Wet AMD
NCT02253030 RECRUITING